NNNS: Diabetes and Glycemic Response (2010)

NNNS: Diabetes and Glycemic Response (2010)

Diabetes, Glycemic Response and Neotame

  • Assessment
    What is the intake of neotame in persons with diabetes, and is this within the Acceptable Daily Intake (ADI) of non-nutritive sweeteners?
    • Conclusion

      To date, no studies were identified to evaluate the intake of neotame in persons with diabetes and whether it is within the ADI of non-nutritive sweeteners.

    • Grade: V
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.
  • Intervention
    Can neotame be used to manage diabetes and glycemic response?
    • Conclusion

      To date, no studies were identified to evaluate the effect of neotame on management of  diabetes and glycemic response.

    • Grade: V
      • Grade I means there is Good/Strong evidence supporting the statement;
      • Grade II is Fair;
      • Grade III is Limited/Weak;
      • Grade IV is Expert Opinion Only;
      • Grade V is Not Assignable.
      • High (A) means we are very confident that the true effect lies close to that of the estimate of the effect;
      • Moderate (B) means we are moderately confident in the effect estimate;
      • Low (C) means our confidence in the effect estimate is limited;
      • Very Low (D) means we have very little confidence in the effect estimate.
      • Ungraded means a grade is not assignable.